LEAD 3387S-40 STIMLOC DBS, Model Number 3387S-40. Electrical implantable device.

FDA Device Recall #Z-0217-2024 — Class II — May 27, 2022

Recall Summary

Recall Number Z-0217-2024
Classification Class II — Moderate risk
Date Initiated May 27, 2022
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Medtronic Neuromodulation
Location Minneapolis, MN
Product Type Devices
Quantity 14 units

Product Description

LEAD 3387S-40 STIMLOC DBS, Model Number 3387S-40. Electrical implantable device.

Reason for Recall

There are a small number of units of the DBS Lead with StimLoc kit (3387S-40) due to a discrepancy in the Use By Date (UBD) printed on the outer packaged kit label versus the UBD printed on the individual product label.

Distribution Pattern

US: MO, FL, TX, WA

Lot / Code Information

UDI/DI 00763000274320, Serial Number VA2JV2V

Other Recalls from Medtronic Neuromodulation

Recall # Classification Product Date
Z-1043-2026 Class II A71200 Vanta" Clinician Programmer Application ... Dec 3, 2025
Z-0996-2026 Class II Restore Clinician Programmer Application (CP Ap... Nov 20, 2025
Z-1704-2025 Class II Enhanced Verify Evaluation Handset (CFN HH90130FA) Apr 3, 2025
Z-1543-2025 Class II Stimulation RC Clinician Programmer Application... Mar 4, 2025
Z-1506-2025 Class II A820 myPTM Software Application associated with... Jan 9, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.